Risk of age-related macular degeneration in men receiving 5α-reductase inhibitors: a population-based cohort study.

Yu-Chen SuChin-Yao ShenShih-Chieh ShaoChi-Chun LaiSheng-Min HsuChaw-Ning LeeChan-Jung LiuJia-Horung HungEdward Chia-Cheng Lai

Published in: Age and ageing (2024)

We found no difference between 5ARIs and tamsulosin regarding the incidence of AMD in BPH patients. However, the risk profiles for AMD differed slightly between dutasteride and finasteride, suggesting that the potency of androgen inhibition is a factor related to AMD incidence.

Keyphrases

age related macular degeneration
benign prostatic hyperplasia
lower urinary tract symptoms
end stage renal disease
risk factors
ejection fraction
chronic kidney disease
newly diagnosed
prognostic factors
peritoneal dialysis
patient reported outcomes
patient reported